Showing results (51-60 of 97) with videos related to
Sort By:
Pageof 10
Haematologica|October 14, 2011
Therapy-related myeloid neoplasms following treatment with radioiodineThomas Schroeder, Andrea Kuendgen, Sabine Kayser, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study groupVerena I Gaidzik, Peter Paschka, Daniela Späth, et al.Leukemia Research|April 28, 2012
Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?Athena M Cherry, Marilyn L Slovak, Lynda J Campbell, et al.Hemasphere|September 24, 2024
Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real-world cohort of patients with lower-risk MDSPaolo Mazzeo, Christina Ganster, John Wiedenhöft, et al.British Journal of Haematology|December 22, 2017
Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in NagasakiMakiko Horai, Shinya Satoh, Masatoshi Matsuo, et al.Blood|August 30, 2007
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patientsDetlef Haase, Ulrich Germing, Julie Schanz, et al.Annals of Hematology|September 6, 2025
Comparison of prognostication by IPSS-M, IPSS-R and AIPSS-MDS in the context of limited availability of molecular data in daily clinical practiceFelicitas Schulz, Carolin Kellersmann, Beate Betz, et al.Ejhaem|May 19, 2023
Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotypeMar Mallo, Heinz Tuechler, Leonor Arenillas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2010
Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98ARichard F Schlenk, Konstanze Döhner, Silja Mack, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 23, 2022
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS StudyUwe Platzbecker, Katharina S Götze, Philipp Kiewe, et al.Pageof 10